634 related articles for article (PubMed ID: 26842965)
21. [A mice model of amyotrophic lateral sclerosis expressing mutant human FUS protein].
Deĭkin AV; Kovrazhkina EA; Ovchinnikov RK; Bronovitskiĭ EV; Razinskaia OD; Smirnov AP; Ermolkevich TG; Eliakov AB; Popov AN; Fedorov EN; Lytkina OA; Kukharskiĭ MS; Tarasova TV; Shelkovnikova TA; Ustiugov AA; Ninkina NN; Gol'dman IL; Sadchikova ER; Bachurin SO; Skvortsova VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):62-9. PubMed ID: 25345633
[TBL] [Abstract][Full Text] [Related]
22. FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy.
Funikov SY; Rezvykh AP; Mazin PV; Morozov AV; Maltsev AV; Chicheva MM; Vikhareva EA; Evgen'ev MB; Ustyugov AA
Neurogenetics; 2018 Aug; 19(3):189-204. PubMed ID: 29982879
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS.
Bourefis AR; Campanari ML; Buee-Scherrer V; Kabashi E
Neurobiol Dis; 2020 Aug; 142():104935. PubMed ID: 32380281
[TBL] [Abstract][Full Text] [Related]
24. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.
Sun S; Ling SC; Qiu J; Albuquerque CP; Zhou Y; Tokunaga S; Li H; Qiu H; Bui A; Yeo GW; Huang EJ; Eggan K; Zhou H; Fu XD; Lagier-Tourenne C; Cleveland DW
Nat Commun; 2015 Jan; 6():6171. PubMed ID: 25625564
[TBL] [Abstract][Full Text] [Related]
25. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
[TBL] [Abstract][Full Text] [Related]
27. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients.
Guo W; Naujock M; Fumagalli L; Vandoorne T; Baatsen P; Boon R; Ordovás L; Patel A; Welters M; Vanwelden T; Geens N; Tricot T; Benoy V; Steyaert J; Lefebvre-Omar C; Boesmans W; Jarpe M; Sterneckert J; Wegner F; Petri S; Bohl D; Vanden Berghe P; Robberecht W; Van Damme P; Verfaillie C; Van Den Bosch L
Nat Commun; 2017 Oct; 8(1):861. PubMed ID: 29021520
[TBL] [Abstract][Full Text] [Related]
28. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
[TBL] [Abstract][Full Text] [Related]
29. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
[TBL] [Abstract][Full Text] [Related]
30. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of an ALS-associated FUS mutation in
Markert SM; Skoruppa M; Yu B; Mulcahy B; Zhen M; Gao S; Sendtner M; Stigloher C
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33148607
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo.
Gogia N; Sarkar A; Mehta AS; Ramesh N; Deshpande P; Kango-Singh M; Pandey UB; Singh A
Neurobiol Dis; 2020 Jul; 140():104837. PubMed ID: 32199908
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.
Mitchell JC; McGoldrick P; Vance C; Hortobagyi T; Sreedharan J; Rogelj B; Tudor EL; Smith BN; Klasen C; Miller CC; Cooper JD; Greensmith L; Shaw CE
Acta Neuropathol; 2013 Feb; 125(2):273-88. PubMed ID: 22961620
[TBL] [Abstract][Full Text] [Related]
34. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
[TBL] [Abstract][Full Text] [Related]
35. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation.
Tateishi T; Hokonohara T; Yamasaki R; Miura S; Kikuchi H; Iwaki A; Tashiro H; Furuya H; Nagara Y; Ohyagi Y; Nukina N; Iwaki T; Fukumaki Y; Kira J
Acta Neuropathol; 2010 Mar; 119(3):355-64. PubMed ID: 19967541
[TBL] [Abstract][Full Text] [Related]
36. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
Qiu H; Lee S; Shang Y; Wang WY; Au KF; Kamiya S; Barmada SJ; Finkbeiner S; Lui H; Carlton CE; Tang AA; Oldham MC; Wang H; Shorter J; Filiano AJ; Roberson ED; Tourtellotte WG; Chen B; Tsai LH; Huang EJ
J Clin Invest; 2014 Mar; 124(3):981-99. PubMed ID: 24509083
[TBL] [Abstract][Full Text] [Related]
37. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
Schütz B
Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
39. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
40. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
